Anderson J P, Patel M V, Thompson G K. "Method for the Synthesis of Sofosbuvir Impurity 43" [P]. US Patent, US 11332295 B2, 2021-12-14.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 索磷布韦杂质43 in Pharmaceutical Formulations". Anal. Methods, 2011, 432, 6605-6620.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 索磷布韦杂质43 as an Impurity". Rapid Commun. Mass Spectrom., 2021, 959, (2), 9564-9582.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Sofosbuvir Impurity 43 Using HRMS and NMR". J. Chromatogr. A, 2024, 1520, (9), 3568-3580.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 索磷布韦杂质43 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2015, 617, (5), 7930-7937.